Jun 30, 2019

Neurocrine Biosciences Q2 2019 Earnings Report

Total Revenue
$184M
Previous year: $96.9M
+89.4%
EPS
$0.32
Previous year: -$0.07
-557.1%
Gross Profit
$182M
Previous year: $96.1M
+89.5%
Cash and Equivalents
$141M
Previous year: $166M
-15.3%
Free Cash Flow
$59.7M
Previous year: $15.8M
+276.9%
Total Assets
$1.07B
Previous year: $841M
+26.8%

Neurocrine Biosciences

Neurocrine Biosciences